ICT-107 is an autologous DC vaccine targeting six tumor antigens (MAGE-1, HER-2, AIM-2, TRP-2, gp100, IL-13Rα2) specifically overexpressed in glioma stem cells. This evidence concerns the gene ERBB2 and neoplasm.